COVID-19 大流行首轮高峰对三级肾癌转诊中心的影响
该回顾性分析评估了 COVID-19 大流行对皇家自由伦敦 NHS 基金会信托肾癌专科中心诊疗路径的影响。2020 年 3 月 18 日暂停择期手术并按 EAU 指南优先分级,封锁 7 周内 SMDT 讨论 234 例(较前 7 周 446 例下降 53%),低优先级 62 例中 27 例(43.5%)推迟,术后仅 1 例(4%)感染 COVID-19 并完全康复,推迟手术者未见临床或病理分期升级增加。
要点
- 封锁 7 周 SMDT 讨论病例数较前下降 53%,小而无症状肾肿块转诊减少更明显。
- 低优先级患者 62 例中 27 例(43.5%)手术推迟,未见临床或病理分期升级增加。
- 术后仅 1 例(4%)发生 COVID-19 感染并完全康复。
核心结论
- COVID-19 首轮高峰严重冲击三级肾癌中心的诊断、转诊与治疗。
- 采用优先分级和 COVID 防护路径可维持时效性肿瘤干预能力,未观察到直接临床损害。
研究设计与样本
- 回顾性分析皇家自由伦敦 NHS 基金会信托肾癌专科中心患者与路径特征。
- 比较 COVID-19 高峰前与封锁期间(2020 年 3 月 23 日至 5 月 10 日,共 7 周)的诊疗情况。
- 2020 年 3 月 18 日暂停择期手术,按欧洲泌尿外科学会(EAU)指南进行优先分级。
主要发现
- 封锁 7 周内 SMDT 讨论 234 例,较封锁前 7 周的 446 例下降 53%。
- 小而无症状肾肿块转诊减少更明显。
- 62 例低优先级癌症患者中 27 例(43.5%)被推迟手术。
- 术后仅 1 例(4%)发生 COVID-19 感染,患者完全康复。
- 推迟手术患者与 COVID 前实践相比,未检测到临床或病理分期升级增加。
关键数值与推荐
- 按 EAU 指南对患者进行优先分级。
- 维持门诊和专科多学科团队(SMDT)会议并保持物理距离。
- 肾手术转移至 COVID 防护站点,并执行感染预防措施。
临床怎么用
- 疫情等资源紧张时期可按 EAU 指南优先分级以维持时效性肿瘤干预。
- 建立 COVID 防护路径和手术站点有助于保障肾癌手术安全。
- 对低优先级患者推迟手术需密切监测,但短期未见分期升级增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To analyse the impact of the COVID-19 pandemic on a centralized specialist kidney cancer care pathway. MATERIALS AND METHODS: We conducted a retrospective analysis of patient and pathway characteristics including prioritization strategies at the Specialist Centre for Kidney Cancer located at the Royal Free London NHS Foundation Trust (RFH) before and during the surge of COVID-19. RESULTS: On 18 March 2020 all elective surgery was halted at RFH to redeploy resources and staff for the COVID-19 surge. Prioritizing of patients according to European Association of Urology guidance was introduced. Clinics and the specialist multidisciplinary team (SMDT) meetings were maintained with physical distancing, kidney surgery was moved to a COVID-protected site, and infection prevention measurements were enforced. During the 7 weeks of lockdown (23 March to 10 May 2020), 234 cases were discussed at the SMDT meetings, 53% compared to the 446 cases discussed in the 7 weeks pre-lockdown. The reduction in referrals was more pronounced for small and asymptomatic renal masses. Of 62 low-priority cancer patients, 27 (43.5%) were deferred. Only one (4%) COVID-19 infection occurred postoperatively, and the patient made a full recovery. No increase in clinical or pathological upstaging could be detected in patients who underwent deferred surgery compared to pre-COVID practice. CONCLUSION: The first surge of the COVID-19 pandemic severely impacted diagnosis, referral and treatment of kidney cancer at a tertiary referral centre. With a policy of prioritization and COVID-protected pathways, capacity for time-sensitive oncological interventions was maintained and no immediate clinical harm was observed.
引用
- Kuusk T, Cullen D, Neves JB, et al. Impact of the first surge of the COVID-19 pandemic on a tertiary referral centre for kidney cancer. BJU Int. 2021. PMID: 33964109. doi:10.1111/bju.15441
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。